O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-7.79%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.22B
AUM Growth
+$5.22B
(-18%)
Cap. Flow
-$466M
Cap. Flow
% of AUM
-8.93%
Top 10 Holdings %
Top 10 Hldgs %
39.09%
Holding
140
New
13
Increased
17
Reduced
36
Closed
24
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$161M |
| 2 |
Humana
HUM
|
$46.5M |
| 3 |
BLU
BELLUS Health Inc.
BLU
|
$45.1M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$41.7M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$32.3M |
Top Sells
| 1 |
Agilent Technologies
A
|
$66.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
$61M |
| 3 |
Boston Scientific
BSX
|
$60.4M |
| 4 |
Merck
MRK
|
$51.9M |
| 5 |
Illumina
ILMN
|
$51.6M |
Sector Composition
| 1 | Healthcare | 98.11% |
| 2 | Financials | 1.43% |
